CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Follow-Up Questions
CapsoVision Inc 'in CEO'su kimdir?
Mr. Kang-Huai Wang 2006 'den beri şirketle birlikte olan CapsoVision Inc 'in President 'ıdır.
CV hissesinin fiyat performansı nasıl?
CV 'in mevcut fiyatı $4.83 'dir, son işlem günde 0.14% decreased etti.
CapsoVision Inc için ana iş temaları veya sektörler nelerdir?
CapsoVision Inc Health Care endüstrisine ait ve sektör Health Care 'dir
CapsoVision Inc 'in piyasa değerlemesi nedir?
CapsoVision Inc 'in mevcut piyasa değerlemesi $226.0M 'dir
CapsoVision Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 5 analist CapsoVision Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 6 al, 1 tut, 0 sat ve 3 güçlü sat içermektedir
